Inaxaplin
Cross-source consensus on Inaxaplin from 1 sources and 26 claims.
1 sources · 26 claims
Uses
How it works
Benefits
Dosage & preparation
Evidence quality
Highlighted claims
- Inaxaplin targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug that targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease in individuals carrying two APOL1 risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug that directly targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug that directly targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug that targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug targeting APOL1 that demonstrates efficacy in treating proteinuric kidney disease. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug that targets APOL1 and demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 high-risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug targeting APOL1 that demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems
- Inaxaplin is a drug targeting APOL1 that demonstrates efficacy in treating proteinuric kidney disease in individuals with two APOL1 risk variants. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems